Efficacy, safety and genomic analysis of SCT200, an anti-EGFR monoclonal antibody, in patients with fluorouracil, irinotecan and oxaliplatin refractory RAS and BRAF wild-type metastatic colorectal cancer: a phase Ⅱ study
-
Published:2024-02
Issue:
Volume:100
Page:104966
-
ISSN:2352-3964
-
Container-title:eBioMedicine
-
language:en
-
Short-container-title:eBioMedicine
Author:
Yang Lin, Zhang Wen, Fan Nanfeng, Cao Peiguo, Cheng Ying, Zhu Lingjun, Luo Suxia, Zong Hong, Bai Yuxian, Zhou Jianfeng, Deng Yanhong, Ba Yi, Liu Tianshu, Aili Mayinuer, Yin Xianli, Gu Kangsheng, Dai Guanghai, Ying Jieer, Shi Jianhua, Gao Yajie, Li Wei, Yu Guohua, Xie Liangzhi, Gai Wenlin, Wang Yan, Meng Peng, Shi YuankaiORCID
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Monoclonal Antibody Therapies in Cancer Immunotherapy;Advances in Medical Diagnosis, Treatment, and Care;2024-08-28
|
|